Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Multiple Sclerosis Center of Northeastern New York is a premier clinical and research facility dedicated to the diagnosis and management of multiple sclerosis (MS) and related neuroimmunological disorders. Located in Latham, New York, the center provides a multidisciplinary care model that integrates advanced neurology, specialized nursing, and comprehensive infusion services for disease-modifying therapies. As a high-volume clinical research site, the center has participated in over 100 clinical trials, contributing significantly to the development of many currently FDA-approved MS medications. The facility is recognized by the National Multiple Sclerosis Society as a Center for Comprehensive MS Care, reflecting its commitment to high-quality, patient-centered treatment. Led by founder Dr. Keith Edwards, the center serves as a vital resource for patients in the Northeastern United States seeking access to cutting-edge therapies and expert clinical expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Multiple Sclerosis Center of Northeastern New York.